CompletedNCT01751386
Baclofen Compared With Placebo for Anxiety and Alcohol Use
About this title
Read the official source — NCT01751386Medication studyAges 21–65United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
What did participation involve?
Participants take baclofen or a placebo (an inactive comparison treatment), depending on their group. An overnight stay includes blood tests, questions about mood and behaviour, and tests involving the choice to drink alcohol.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateDecember 3, 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 39
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT01751386
- Official title
Show the full official title
A Double-Blind, Placebo-Controlled, Randomized Human Laboratory Pilot Study of Baclofen in Anxious Alcoholics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to take study medication.
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Baclofen.
Who was this study for?
Listed age limits: 21 years to 65 years.
